» Articles » PMID: 39102190

"Brain Fog" After COVID-19 Infection: How the Field of Neuropsychology Can Help Clear the Air

Overview
Date 2024 Aug 5
PMID 39102190
Authors
Affiliations
Soon will be listed here.
Abstract

The chapter explores the role of neuropsychology in understanding brain fog as a subjective complaint in the context of COVID-19. It discusses the historical and medical significance of the term "brain fog" and its psychological and neurological aspects. The chapter identifies the cognitive domains commonly affected by brain fog, such as attention, executive function, memory, and language. Additionally, it emphasizes the impact of societal changes during the COVID-19 pandemic on the general population as a crucial backdrop for understanding the issue. The chapter also highlights the important role of clinical and research neuropsychologists in gaining clarity on grouped data and individual patients' cognitive and emotional difficulties after COVID-19 infection. It discusses indications for neuropsychological rehabilitation and therapy and describes typical therapy phases and methods, including new approaches like telemedicine, virtual reality, and mobile app-based rehabilitation and self-tracking. The chapter underscores that experiences of brain fog can vary among COVID-19 patients and may change over time. It provides clinicians and interested parties with an in-depth understanding of brain fog and its manifestations, concomitant subtypes, and concrete strategies for addressing it. The chapter emphasizes the critical role of neuropsychology in scientifically examining brain fog and advocating for personalized approaches to cognitive rehabilitation.

References
1.
Adamis D, Treloar A, Martin F, Macdonald A . A brief review of the history of delirium as a mental disorder. Hist Psychiatry. 2008; 18(72 Pt 4):459-69. DOI: 10.1177/0957154X07076467. View

2.
Akin-Sari B, Inozu M, Haciomeroglu A, Trak E, Tufan D, Doron G . Cognitive training using a mobile app as a coping tool against COVID-19 distress: A crossover randomized controlled trial. J Affect Disord. 2022; 311:604-613. PMC: 9137239. DOI: 10.1016/j.jad.2022.05.118. View

3.
Akinci B, Erkan Ogul O, Hanoglu L, Kulac B, Oren D, Ulu O . Evaluation of cognitive functions in adult individuals with COVID-19. Neurol Sci. 2022; 44(3):793-802. PMC: 9793347. DOI: 10.1007/s10072-022-06562-2. View

4.
Al-Refae M, Al-Refae A, Munroe M, Sardella N, Ferrari M . A Self-Compassion and Mindfulness-Based Cognitive Mobile Intervention (Serene) for Depression, Anxiety, and Stress: Promoting Adaptive Emotional Regulation and Wisdom. Front Psychol. 2021; 12:648087. PMC: 8019776. DOI: 10.3389/fpsyg.2021.648087. View

5.
Alemanno F, Houdayer E, Parma A, Spina A, Del Forno A, Scatolini A . COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience. PLoS One. 2021; 16(2):e0246590. PMC: 7870071. DOI: 10.1371/journal.pone.0246590. View